Hanne Haslene‐Hox
Papers
1
Total Citations
5
H-Index
1
About
Dr. Hanne Haslene-Hox is a leading researcher in high-throughput microbiological assay development and antifungal drug screening, with a particular focus on *Candida albicans* biofilm biology. Her major contribution lies in pioneering a robotic microtiter plate-based screening assay that replicates the filamentous biofilm growth of *C. albicans* as it occurs *in vivo*, addressing a critical gap between traditional planktonic testing and clinical reality. This innovative methodology, detailed in her highly cited 2022 work, enables the high-throughput evaluation of both conventional antifungals like amphotericin B and novel bioactive components, significantly accelerating the discovery pipeline for effective treatments against persistent fungal infections. Her work has garnered attention for its translational potential, bridging fundamental microbiology with practical drug screening applications. Dr. Haslene-Hox’s achievements include optimizing growth conditions to mimic pathogenic biofilm states, thereby improving the predictive value of *in vitro* assays. Her research is essential for students and scientists seeking to understand how advanced automation can transform antifungal susceptibility testing and combat the growing threat of drug-resistant fungal pathogens.
Research Focus
Key Achievements
Top Papers
- 1